Delivery Order SPE2DB20D7059-SPE2DB24FPZY2

Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,148,082 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract has a ceiling value of $4,633.76 and a period of performance through April 3, 2024. This order was issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,564,184,313 units of Fluticasone Prop HFA 110 MCG 12GM. The $3,843.09 firm-fixed-price contract has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,414,074 units of FLUTICASONE PROP HFA 44 MCG 10.6GM. The $1,161.90 order has a completion date of January 24, 2024 and was issued on January 23, 2024. This delivery order is part of Amerisourcebergen's broader contract to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. The company has...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM. The contract has a potential value of $1,234.00 and a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a $19,013.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,860,781 units of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. This delivery order contract is part of a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract has a ceiling value of $1,672.97 and a completion date of May 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,176,783 units of Fluticasone Propionate HFA 220 MCG 12GM. The contract has a ceiling value of $2,318.50 and a performance period through April 8, 2024. This award is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31,...
This is a $4,487.28 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,590,966 units of the medication Fluticasone Prop HFA 220 MCG 12GM. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $5,167.84 to Amerisourcebergen Drug Corp, a for-profit organization, to provide fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a completion date of February 9, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and medical...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FPZY2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,779,138 units of the drug fluticasone propionate HFA 110 mcg 12 gm. The contract has a completion date of February 28, 2024 and a potential value of $2,071.60. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.

Generated 6/2/24, 12:47 AM